277 related articles for article (PubMed ID: 10479719)
1. Anatomy of an endogenous antagonist: relationship between Agouti-related protein and proopiomelanocortin in brain.
Bagnol D; Lu XY; Kaelin CB; Day HE; Ollmann M; Gantz I; Akil H; Barsh GS; Watson SJ
J Neurosci; 1999 Sep; 19(18):RC26. PubMed ID: 10479719
[TBL] [Abstract][Full Text] [Related]
2. Knockout studies defining different roles for melanocortin receptors in energy homeostasis.
Butler AA; Cone RD
Ann N Y Acad Sci; 2003 Jun; 994():240-5. PubMed ID: 12851322
[TBL] [Abstract][Full Text] [Related]
3. Neither agouti-related protein nor neuropeptide Y is critically required for the regulation of energy homeostasis in mice.
Qian S; Chen H; Weingarth D; Trumbauer ME; Novi DE; Guan X; Yu H; Shen Z; Feng Y; Frazier E; Chen A; Camacho RE; Shearman LP; Gopal-Truter S; MacNeil DJ; Van der Ploeg LH; Marsh DJ
Mol Cell Biol; 2002 Jul; 22(14):5027-35. PubMed ID: 12077332
[TBL] [Abstract][Full Text] [Related]
4. Relationship of α-MSH and AgRP axons to the perikarya of melanocortin-4 receptor neurons.
Lima LB; Pedroso JAB; Metzger M; Gautron L; Donato J
Brain Res; 2019 Aug; 1717():136-146. PubMed ID: 31009611
[TBL] [Abstract][Full Text] [Related]
5. Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants.
Haskell-Luevano C; Cone RD; Monck EK; Wan YP
Biochemistry; 2001 May; 40(20):6164-79. PubMed ID: 11352754
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship of (1-aryl-2-piperazinylethyl)piperazines: antagonists for the AGRP/melanocortin receptor binding.
Arasasingham PN; Fotsch C; Ouyang X; Norman MH; Kelly MG; Stark KL; Karbon B; Hale C; Baumgartner JW; Zambrano M; Cheetham J; Tamayo NA
J Med Chem; 2003 Jan; 46(1):9-11. PubMed ID: 12502354
[TBL] [Abstract][Full Text] [Related]
7. Common requirements for melanocortin-4 receptor selectivity of structurally unrelated melanocortin agonist and endogenous antagonist, Agouti protein.
Oosterom J; Garner KM; den Dekker WK ; Nijenhuis WA; Gispen WH; Burbach JP; Barsh GS; Adan RA
J Biol Chem; 2001 Jan; 276(2):931-6. PubMed ID: 11024027
[TBL] [Abstract][Full Text] [Related]
8. Melanocortins and their receptors and antagonists.
Voisey J; Carroll L; van Daal A
Curr Drug Targets; 2003 Oct; 4(7):586-97. PubMed ID: 14535656
[TBL] [Abstract][Full Text] [Related]
9. Contribution of melanocortin receptor exoloops to Agouti-related protein binding.
Yang YK; Dickinson CJ; Zeng Q; Li JY; Thompson DA; Gantz I
J Biol Chem; 1999 May; 274(20):14100-6. PubMed ID: 10318826
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Agouti-related protein binding to melanocortin receptors.
Yang YK; Thompson DA; Dickinson CJ; Wilken J; Barsh GS; Kent SB; Gantz I
Mol Endocrinol; 1999 Jan; 13(1):148-55. PubMed ID: 9892020
[TBL] [Abstract][Full Text] [Related]
11. Inverse agonism gains weight.
Adan RA; Kas MJ
Trends Pharmacol Sci; 2003 Jun; 24(6):315-21. PubMed ID: 12823958
[TBL] [Abstract][Full Text] [Related]
12. Loss of agouti-related peptide does not significantly impact the phenotype of murine POMC deficiency.
Corander MP; Rimmington D; Challis BG; O'Rahilly S; Coll AP
Endocrinology; 2011 May; 152(5):1819-28. PubMed ID: 21363936
[TBL] [Abstract][Full Text] [Related]
13. Loops and links: structural insights into the remarkable function of the agouti-related protein.
Millhauser GL; McNulty JC; Jackson PJ; Thompson DA; Barsh GS; Gantz I
Ann N Y Acad Sci; 2003 Jun; 994():27-35. PubMed ID: 12851295
[TBL] [Abstract][Full Text] [Related]
14. Melanocortins and agouti-related protein modulate the excitability of two arcuate nucleus neuron populations by alteration of resting potassium conductances.
Smith MA; Hisadome K; Al-Qassab H; Heffron H; Withers DJ; Ashford ML
J Physiol; 2007 Jan; 578(Pt 2):425-38. PubMed ID: 17068101
[TBL] [Abstract][Full Text] [Related]
15. Involvement of agouti-related protein, an endogenous antagonist of hypothalamic melanocortin receptor, in leptin action.
Ebihara K; Ogawa Y; Katsuura G; Numata Y; Masuzaki H; Satoh N; Tamaki M; Yoshioka T; Hayase M; Matsuoka N; Aizawa-Abe M; Yoshimasa Y; Nakao K
Diabetes; 1999 Oct; 48(10):2028-33. PubMed ID: 10512369
[TBL] [Abstract][Full Text] [Related]
16. Agouti-related protein has an inhibitory paracrine role in the rat adrenal gland.
Dhillo WS; Small CJ; Gardiner JV; Bewick GA; Whitworth EJ; Jethwa PH; Seal LJ; Ghatei MA; Hinson JP; Bloom SR
Biochem Biophys Res Commun; 2003 Jan; 301(1):102-7. PubMed ID: 12535647
[TBL] [Abstract][Full Text] [Related]
17. Molecular determination of agouti-related protein binding to human melanocortin-4 receptor.
Yang Y; Chen M; Lai Y; Gantz I; Yagmurlu A; Georgeson KE; Harmon CM
Mol Pharmacol; 2003 Jul; 64(1):94-103. PubMed ID: 12815165
[TBL] [Abstract][Full Text] [Related]
18. Sustained orexigenic effect of Agouti related protein may be not mediated by the melanocortin 4 receptor.
Kim MS; Rossi M; Abbott CR; AlAhmed SH; Smith DM; Bloom SR
Peptides; 2002 Jun; 23(6):1069-76. PubMed ID: 12126733
[TBL] [Abstract][Full Text] [Related]
19. The interaction of MC3R and MC4R with MRAP2, ACTH, α-MSH and AgRP in chickens.
Zhang J; Li X; Zhou Y; Cui L; Li J; Wu C; Wan Y; Li J; Wang Y
J Endocrinol; 2017 Aug; 234(2):155-174. PubMed ID: 28512117
[TBL] [Abstract][Full Text] [Related]
20. Neural melanocortin receptors are differentially expressed and regulated by stress in rat hypothalamic-pituitary-adrenal axis.
Wachira SJ; Hughes-Darden CA; Nicholas HB; Taylor CV; Robinson TJ
Cell Mol Biol (Noisy-le-grand); 2004 Sep; 50(6):703-13. PubMed ID: 15641161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
